dipyridamole has been researched along with Stevens-Johnson Syndrome in 4 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two cases of Toxic Epidermal Necrolysis, with a previous history of drugs intake, and associated to a lymphoma and to a chronic lymphoid leukemia, are presented." | 1.29 | [Toxic epidermal necrolysis associated with lymphoproliferative syndromes. Anatomo-clinical study. Presentation of 2 cases]. ( Aguado Santos, A; Gomez Duaso, AJ; Ortiz Reina, S; Sanz Asenjo, A; Seoane Leston, JM, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jao, T | 1 |
| Tsai, TH | 1 |
| Jeng, JS | 1 |
| Seoane Leston, JM | 1 |
| Gomez Duaso, AJ | 1 |
| Sanz Asenjo, A | 1 |
| Ortiz Reina, S | 1 |
| Aguado Santos, A | 1 |
| de León Ponce, MD | 1 |
| Valencia, MD | 1 |
| López-Llera Méndez, M | 1 |
| Rubio Linares, G | 1 |
| Dìaz de Leòn-Ponce, M | 1 |
| Gonzàlez-Mendoza, A | 1 |
| Ramìrez-Oropeza, H | 1 |
| Zurita-Carrillo, R | 1 |
| Rojas-Yàñez, E | 1 |
| Ronces-Viveros, R | 1 |
1 trial available for dipyridamole and Stevens-Johnson Syndrome
| Article | Year |
|---|---|
[Therapeutic reevaluation of toxic epidermic necrolysis with pregnancy].
Topics: Adult; Clinical Trials as Topic; Diagnosis, Differential; Dipyridamole; Drug Evaluation; Female; Hum | 1976 |
3 other studies available for dipyridamole and Stevens-Johnson Syndrome
| Article | Year |
|---|---|
Aggrenox (Asasantin retard)-induced Stevens-Johnson syndrome.
Topics: Aged; Aspirin; Aspirin, Dipyridamole Drug Combination; Dipyridamole; Drug Combinations; Female; Huma | 2009 |
[Toxic epidermal necrolysis associated with lymphoproliferative syndromes. Anatomo-clinical study. Presentation of 2 cases].
Topics: Anesthetics; Dipyridamole; Fatal Outcome; Female; Humans; Insulin; Leukemia, Lymphocytic, Chronic, B | 1993 |
[Clinical case. Toxic epidermal necrolysis. Therapeutic advance].
Topics: Administration, Oral; Adult; Dipyridamole; Female; Heparin; Humans; Injections, Intravenous; Stevens | 1973 |